» Articles » PMID: 31578760

What Are the Statistical Implications of Treatment Non-compliance in Cluster Randomized Trials: A Simulation Study

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2019 Oct 4
PMID 31578760
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Subjects in randomized controlled trials do not always comply to the treatment condition they have been assigned to. This may cause the estimated effect of the intervention to be biased and also affect efficiency, coverage of confidence intervals, and statistical power. In cluster randomized trials non-compliance may occur at the subject level but also at the cluster level. In the latter case, all subjects within the same cluster have the same compliance status. The purpose of this study is to investigate the statistical implications of non-compliance in cluster randomized trials. A simulation study was conducted with varying degrees of non-compliance at either the cluster level or subject level. The probability of non-compliance depends on a covariate at the cluster or subject level. Various realistic values of the intraclass correlation coefficient and cluster size are used. The data are analyzed by intention to treat, as treated, per protocol and the instrumental variable approach. The results show non-compliance may result in downward biased estimates of the intervention effect and an under- or overestimate of its standard deviation. The coverage of the confidence intervals may be too small, and in most cases, empirical power is too small. The results are more severe when the probability of non-compliance increases and the covariate that affects compliance is unobserved. It is advocated to avoid non-compliance. If this is not possible, compliance status and covariates that affect compliance should be measured and included in the statistical model.

Citing Articles

A systematic review of simulation studies which compare existing statistical methods to account for non-compliance in randomised controlled trials.

Abell L, Maher F, Jennings A, Gray L BMC Med Res Methodol. 2023; 23(1):300.

PMID: 38104108 PMC: 10724933. DOI: 10.1186/s12874-023-02126-w.


A Bayesian Approach for Estimating the Survivor Average Causal Effect When Outcomes Are Truncated by Death in Cluster-Randomized Trials.

Tong G, Li F, Chen X, Hirani S, Newman S, Wang W Am J Epidemiol. 2023; 192(6):1006-1015.

PMID: 36799630 PMC: 10236525. DOI: 10.1093/aje/kwad038.


A Review of the Ring Trial Design for Evaluating Ring Interventions for Infectious Diseases.

Butzin-Dozier Z, Athni T, Benjamin-Chung J Epidemiol Rev. 2022; 44(1):29-54.

PMID: 35593400 PMC: 10362935. DOI: 10.1093/epirev/mxac003.


Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study.

Hossain M, Mosquera L, Karim M BMC Med Res Methodol. 2022; 22(1):46.

PMID: 35172746 PMC: 8849041. DOI: 10.1186/s12874-022-01518-8.


The implications of noncompliance for randomized trials with partial nesting due to group treatment.

Roberts C Stat Med. 2020; 40(2):349-368.

PMID: 33118193 PMC: 7821326. DOI: 10.1002/sim.8778.


References
1.
Brilleman S, Metcalfe C, Peters T, Hollingworth W . The Reporting of Treatment Nonadherence and Its Associated Impact on Economic Evaluations Conducted Alongside Randomized Trials: A Systematic Review. Value Health. 2016; 19(1):99-108. DOI: 10.1016/j.jval.2015.07.009. View

2.
Loeys T, Vansteelandt S, Goetghebeur E . Accounting for correlation and compliance in cluster randomized trials. Stat Med. 2002; 20(24):3753-67. DOI: 10.1002/sim.1169. View

3.
Welsh A . Randomised controlled trials and clinical maternity care: moving on from intention-to-treat and other simplistic analyses of efficacy. BMC Pregnancy Childbirth. 2013; 13:15. PMC: 3554494. DOI: 10.1186/1471-2393-13-15. View

4.
Dodd S, White I, Williamson P . Nonadherence to treatment protocol in published randomised controlled trials: a review. Trials. 2012; 13:84. PMC: 3492022. DOI: 10.1186/1745-6215-13-84. View

5.
Moher D, Hopewell S, Schulz K, Montori V, Gotzsche P, Devereaux P . CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c869. PMC: 2844943. DOI: 10.1136/bmj.c869. View